Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1985
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
publication
Title:
Liponate 2-DH CIR Report April 7, 2015
Author:
Cosmetic Ingredient Review
Year:
2015
Bibliographic source:
CIR Report April 7, 2015
Safety Assessment of PEG Diesters as Used in Cosmetics

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
not specified
Remarks:
It's taken from the publication and the GLP compliance is not specified.
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
study performed in 1985 before the LLNA method

Test material

Constituent 1
Reference substance name:
PEG-4 Diheptanoate
Molecular formula:
UVCB
IUPAC Name:
PEG-4 Diheptanoate
Test material form:
liquid

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: BC/DHA
Sex:
male
Details on test animals and environmental conditions:
10 male

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal and epicutaneous
Vehicle:
other: dimethyl phthalate
Concentration / amount:
0.05 mL and 0.1 mL
Day(s)/duration:
5 weeks
Adequacy of induction:
not specified
Challenge
No.:
#1
Route:
intradermal and epicutaneous
Vehicle:
other: dimethyl phthalate
Concentration / amount:
0.05 mL
Day(s)/duration:
5 weeks
Adequacy of challenge:
not specified
No. of animals per dose:
10 guinea pigs at 0.05 mL and 0.1 mL
Details on study design:
The test substance was administered to the shaved skin of the shoulder of the guinea pigs followed 2 days later by an injection of dimethyl phthalate (1%; 0.1 mL).
Three more injections, 1 week apart, were administered to complete the induction phase. After a 13-day rest period, the challenge was administered as a topical administration of PEG-4 diheptanoate (5% or 50% in dimethyl phthalate; 0.05 mL) to the same shaven shoulder. The control consisted of a group of naïve guinea pigs (n=10) that were administered the challenge. Test sites were evaluated for reactions at 24 and 48 h after administration of the challenge.
Challenge controls:
yes
Positive control substance(s):
yes

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.05 ml
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
rechallenge
Hours after challenge:
24
Group:
negative control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
rechallenge
Hours after challenge:
48
Group:
negative control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
not measured/tested
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
not measured/tested
Key result
Reading:
rechallenge
Hours after challenge:
24
Group:
positive control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
not measured/tested
Key result
Reading:
rechallenge
Hours after challenge:
48
Group:
positive control
Dose level:
0.05 mL
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
not measured/tested

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In a dermal sensitization study using male BC/DHA guinea pigs (n=10), PEG-4 diheptanoate (5% or 25%; 0.05 mL in dimethyl phthalate) was not sensitizing when challenged at 5% or 50%.